Hansoh Pharmaceutical Group Company Limited (HKG:3692)

HKG:3692 Revenue

In the year 2025, Hansoh Pharmaceutical Group Company had annual revenue of 15.03B CNY with 22.57% growth. Hansoh Pharmaceutical Group Company had revenue of 7.59B in the half year ending December 31, 2025, with 35.80% growth.

• Revenue: 15.03B CNY
• Revenue Growth: +22.57%
• P/S Ratio: 10.43
• Revenue / Employee: 1.61M CNY
• Employees: 9,347
• Market Cap: 174.49B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.03B	2.77B	22.57%
Dec 31, 2024	12.26B	2.16B	21.35%
Dec 31, 2023	10.10B	721.40M	7.69%
Dec 31, 2022	9.38B	-552.73M	-5.56%
Dec 31, 2021	9.94B	1.24B	14.33%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 7, 2026

Data Sources Report a data error